Contact
searchSearch
HMP Global

Neurology

Featured

pencil filling out bubble on multiple choice test with a timer in the background
Quiz
P2Y12 Inhibitors and ICH Outcomes
10/27/2026
Maria Mantas
Can you recall how prior P2Y12 therapy affected hospital outcomes in patients with intracerebral hemorrhage? Test your knowledge with this quiz!
Can you recall how prior P2Y12 therapy affected hospital outcomes in patients with intracerebral hemorrhage? Test your knowledge with this quiz!
Can you recall how prior P2Y12...
10/27/2026
Neurology
older adult resting hands on cane
Research Summary
Vascular Risk Factors Associated With Late-Onset Epilepsy in Older Adults
10/22/2026
Maria Mantas
Several vascular risk factors, including smoking, hypertension, diabetes and prior stroke, were associated with LOE in older adults, according to pooled analysis findings.
Several vascular risk factors, including smoking, hypertension, diabetes and prior stroke, were associated with LOE in older adults, according to pooled analysis findings.
Several vascular risk factors,...
10/22/2026
Neurology
trees with leaves falling to represent dementia progression
News
Global Dementia Cases Projected to Double by 2050
10/15/2026
Maria Mantas
A meta-analysis of 38,418 participants across 18 countries or territories estimated 11.4 million new dementia cases globally in 2023, with annual incidence projected to reach 24.7 million by 2050.
A meta-analysis of 38,418 participants across 18 countries or territories estimated 11.4 million new dementia cases globally in 2023, with annual incidence projected to reach 24.7 million by 2050.
A meta-analysis of 38,418...
10/15/2026
Neurology
a physician fills out a discharge form while speaking to a patient
Research Summary
Early Ocrelizumab Shows Sustained Long-Term Benefit in Relapsing MS
10/06/2026
Maria Mantas
Treatment with ocrelizumab for up to 10 years was associated with sustained relapse control and minimal disability accrual in patients with relapsing MS, according to phase 3 findings.
Treatment with ocrelizumab for up to 10 years was associated with sustained relapse control and minimal disability accrual in patients with relapsing MS, according to phase 3 findings.
Treatment with ocrelizumab for...
10/06/2026
Neurology
FDA approval stamp
FDA Approval
FDA Approves Tavapadon for Adults With Parkinson Disease
09/28/2026
Maria Mantas
The US Food and Drug Administration (FDA) has approved tavapadon (JUVMO) tablets for the treatment of Parkinson disease in adults, announced manufacturer AbbVie.
The US Food and Drug Administration (FDA) has approved tavapadon (JUVMO) tablets for the treatment of Parkinson disease in adults, announced manufacturer AbbVie.
The US Food and Drug...
09/28/2026
Neurology
sticky note that reads "take the quiz"
Quiz
Plasma Biomarkers in FTD
08/03/2026
Maria Mantas
Can you recall which plasma biomarkers were associated with greater cognitive decline in frontotemporal dementia?
Can you recall which plasma biomarkers were associated with greater cognitive decline in frontotemporal dementia?
Can you recall which plasma...
08/03/2026
Neurology
a hand points to a specific spot on a brain scan
News
P2Y12 Inhibitors Linked to Worse Intracerebral Hemorrhage Outcomes in Nationwide Study
07/13/2026
Maria Mantas
A nationwide cohort study found that prior use of P2Y12 inhibitors, either alone or combined with aspirin, was associated with more severe presentation and worse hospital outcomes in patients with spontaneous ICH.
A nationwide cohort study found that prior use of P2Y12 inhibitors, either alone or combined with aspirin, was associated with more severe presentation and worse hospital outcomes in patients with spontaneous ICH.
A nationwide cohort study found...
07/13/2026
Neurology
a researcher holds up a test tube of blood
News
Plasma p-tau217/Aβ42 Test Accuracy Reduced in Patients With Traumatic Brain Injury
07/06/2026
Maria Mantas
Plasma p-tau217/Aβ42 ratio accurately detected amyloid-PET positivity in veterans without traumatic brain injury (TBI), but accuracy declined significantly in those with prior TBI. 
Plasma p-tau217/Aβ42 ratio accurately detected amyloid-PET positivity in veterans without traumatic brain injury (TBI), but accuracy declined significantly in those with prior TBI. 
Plasma p-tau217/Aβ42 ratio...
07/06/2026
Neurology
doctor holds hands with an older woman patient sitting on the couch
News
Higher Parity May Accelerate Preclinical Alzheimer’s Changes in Postmenopausal Women
06/29/2026
Maria Mantas
A longitudinal study reports that parity may modify the relationship between Alzheimer disease (AD) pathology and brain aging in cognitively unimpaired postmenopausal women.
A longitudinal study reports that parity may modify the relationship between Alzheimer disease (AD) pathology and brain aging in cognitively unimpaired postmenopausal women.
A longitudinal study reports...
06/29/2026
Neurology
an illustration of a brain in white against a black background with a red area indicating stroke
Quiz
2026 AHA/ASA Acute Ischemic Stroke Guidelines
06/22/2026
Brionna Mendoza
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
06/22/2026
Neurology
an older woman sits on a couch looking out the window
Research Summary
Frontal Release Signs Linked to Future Dementia Risk in Older Adults
06/17/2026
Maria Mantas
The presence of frontal release signs (FRS), primitive reflexes that reemerge with neurodegeneration or brain injury, may help identify older adults at increased risk for future cognitive decline, according to a cohort study.
The presence of frontal release signs (FRS), primitive reflexes that reemerge with neurodegeneration or brain injury, may help identify older adults at increased risk for future cognitive decline, according to a cohort study.
The presence of frontal release...
06/17/2026
Neurology

Alzheimer's Disease & Cognitive Disorders Symposium

Logo of the Alzheimer's Disease and Cognitive Disorders Symposium
Press Release
HMP Global’s Popular Alzheimer’s Disease and Cognitive Disorders Symposium Spurs In-Person 2026 Meeting in Orlando
12/18/2025
More than 800 participants joined the 2025 virtual program; the December 4-6, 2026 event will deepen engagement through richer education and collaborative learning.
More than 800 participants joined the 2025 virtual program; the December 4-6, 2026 event will deepen engagement through richer education and collaborative learning.
More than 800 participants...
12/18/2025
Psych Congress Network
fruits, vegetables, and lean meats
Conference Coverage
Cognitive Resilience Strategies Spotlighted at ADCD Symposium
11/14/2025
Brionna Mendoza
Co-Chair Mark Agronin, MD, and James Galvin, MD, MPH, discuss connected epidemiology, lifestyle, and emerging immunotherapies to pragmatic dementia-prevention frameworks for clinical practice in Alzheimer disease treatment and prevention for...
Co-Chair Mark Agronin, MD, and James Galvin, MD, MPH, discuss connected epidemiology, lifestyle, and emerging immunotherapies to pragmatic dementia-prevention frameworks for clinical practice in Alzheimer disease treatment and prevention for...
Co-Chair Mark Agronin, MD, and...
11/14/2025
Neurology
brain
Conference Coverage
Experts Explore Neuropsychiatric Symptoms in Alzheimer Disease at Inaugural ADCD Symposium
11/13/2025
Maria Mantas
On the first day of the Alzheimer’s Disease and Cognitive Disorders (ADCD) Symposium, meeting Co-Chair Marc E. Agronin, MD, and Carolyn K. Clevenger, DNP, GNP-BC, presented on common neuropsychiatric symptoms that may impact patients with...
On the first day of the Alzheimer’s Disease and Cognitive Disorders (ADCD) Symposium, meeting Co-Chair Marc E. Agronin, MD, and Carolyn K. Clevenger, DNP, GNP-BC, presented on common neuropsychiatric symptoms that may impact patients with...
On the first day of the...
11/13/2025
Neurology
Alzheimer Disease & Cognitive Disorders Symposium
Conference Preview
First Annual ADCD Symposium to ‘Bridge the Gap’ in Alzheimer Disease Education
11/05/2025
Brionna Mendoza
Get a sneak peek into the first annual ADCD Symposium, convening November 12 to 13, 2025!
Get a sneak peek into the first annual ADCD Symposium, convening November 12 to 13, 2025!
Get a sneak peek into the first...
11/05/2025
Neurology
Alzheimer Disease & Cognitive Disorders Symposium
Conference Coverage
Alzheimer's Disease and Cognitive Disorders Symposium: Agenda Highlights
07/17/2025
Marwan Sabbagh, MD
Learn more about the Alzheimer's Disease and Cognitive Disorder Symposium with this video from Co-Chair Marwan Sabbagh, MD, FAAN, FANA.
Learn more about the Alzheimer's Disease and Cognitive Disorder Symposium with this video from Co-Chair Marwan Sabbagh, MD, FAAN, FANA.
Learn more about the Alzheimer's...
07/17/2025
Neurology
ADCD symposium
Conference Coverage
Introducing the Alzheimer's Disease and Cognitive Disorders Symposium
07/07/2025
Marc E. Agronin, MD; W. Clay Jackson, MD, DipTh
Meeting co-chairs Marc Agronin and W. Clay Jackson introduce this new symposium and share why healthcare providers should attend.
Meeting co-chairs Marc Agronin and W. Clay Jackson introduce this new symposium and share why healthcare providers should attend.
Meeting co-chairs Marc Agronin...
07/07/2025
Neurology
marc agronin md
Faculty Insights
Alzheimer Disease Prevention: Part 2
07/29/2024
Marc E. Agronin, MD
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated sequel to his 2022 blog, Marc Agronin, MD, geriatric psychiatry section editor at Psych Congress Network, offers deeper expert clinical insights on Alzheimer disease prevention.
In this highly anticipated...
07/29/2024
Psych Congress Network

NEI Congress

tipped over pill bottle with white pills spilling out
News
Olanzapine/Samidorphan Offers Observable Benefit for Treatment of Negative Schizophrenia Symptoms
06/09/2025
Maria Mantas
The combination of olanzapine and samidorphan (OLZ/SAM) may have a significant long-term treatment benefit on the negative symptoms of schizophrenia, according to research presented at the 2025 NEI Spring Congress.
The combination of olanzapine and samidorphan (OLZ/SAM) may have a significant long-term treatment benefit on the negative symptoms of schizophrenia, according to research presented at the 2025 NEI Spring Congress.
The combination of olanzapine...
06/09/2025
Psych Congress Network
woman experiencing depression
News
LMF Effective as Adjunct Treatment in SSRI-Resistant Depression, Review Finds
05/12/2025
Maria Mantas
According to a recent literature review, L-methylfolate (LMF) is an effective adjunct treatment in selective serotonin reuptake inhibitor (SSRI)-resistant depression, particularly at 15 mg/day.
According to a recent literature review, L-methylfolate (LMF) is an effective adjunct treatment in selective serotonin reuptake inhibitor (SSRI)-resistant depression, particularly at 15 mg/day.
According to a recent literature...
05/12/2025
Psych Congress Network
poster presentation session at a conference
Conference Coverage
Deutetrabenazine Targets VMAT2 With Precision, Analysis Finds
05/12/2025
Jolynn Tumolo
Deutetrabenazine showed significant efficacy and high specificity in inhibiting its primary target, VMAT2,, in functional assessments of the drug’s deuterated metabolites. Findings were reported at the inaugural poster session at the NEI...
Deutetrabenazine showed significant efficacy and high specificity in inhibiting its primary target, VMAT2,, in functional assessments of the drug’s deuterated metabolites. Findings were reported at the inaugural poster session at the NEI...
Deutetrabenazine showed...
05/12/2025
Psych Congress Network
pink pill bottle with white pills spilling out
News
Effective Pharmacologic Interventions for Pathological Gambling Remain Limited
05/09/2025
Maria Mantas
A systematic review presented at the 2025 NEI Spring Congress found that effective pharmacologic interventions for pathological gambling (PG) remain limited. 
A systematic review presented at the 2025 NEI Spring Congress found that effective pharmacologic interventions for pathological gambling (PG) remain limited. 
A systematic review presented at...
05/09/2025
Psych Congress Network
healthy foods in an outline of a person's head
News
Study Finds Nutritional Toolkit Implementation Feasible in Outpatient Mental Health Settings
05/09/2025
Maria Mantas
A recent quality improvement project presented in a poster at the 2025 NEI Spring Congress explored ways to improve nutritional screening and education in outpatient mental health settings. 
A recent quality improvement project presented in a poster at the 2025 NEI Spring Congress explored ways to improve nutritional screening and education in outpatient mental health settings. 
A recent quality improvement...
05/09/2025
Psych Congress Network
An illustrated picture shows two cartoon doctors, one holding up a magnifying glass to a cartoon brain.
Conference Coverage
Flexible Dosing of Esketamine Nasal Spray Effective Over Long-Term
11/12/2024
Jolynn Tumolo; Brionna Mendoza
Analysis of a long-term extension study of flexibly dosed esketamine nasal spray, in combination with an oral antidepressant, found durable long-term efficacy and safety of the treatment whether dosed weekly, every other week, or every 4...
Analysis of a long-term extension study of flexibly dosed esketamine nasal spray, in combination with an oral antidepressant, found durable long-term efficacy and safety of the treatment whether dosed weekly, every other week, or every 4...
Analysis of a long-term...
11/12/2024
Psych Congress Network
A illustrated cartoon of someone sitting under a raincloud
Conference Coverage
Anhedonia Highlighted as a Frequently Misunderstood Symptom in Psychiatric Conditions at 2024 NEI Fall Congress
11/11/2024
Brionna Mendoza
Anhedonia is a common feature of depression and other psychiatric conditions. Distinct from emotional blunting or apathy, patients experiencing anhedonia, “have a reduced ability to experience pleasure or interest in things previously...
Anhedonia is a common feature of depression and other psychiatric conditions. Distinct from emotional blunting or apathy, patients experiencing anhedonia, “have a reduced ability to experience pleasure or interest in things previously...
Anhedonia is a common feature of...
11/11/2024
Psych Congress Network
Thomas L. Schwartz, MD
Q&As
How Psychiatrists Can Address Sleep-Wake Disorders Effectively
11/09/2024
Thomas Schwartz, MD
Thomas L. Schwartz, MD, shares exclusive insights from his session on sleep-wake issues presented at the 2024 NEI Fall Congress.
Thomas L. Schwartz, MD, shares exclusive insights from his session on sleep-wake issues presented at the 2024 NEI Fall Congress.
Thomas L. Schwartz, MD, shares...
11/09/2024
Psych Congress Network
Stephen M. Stahl
Conference Coverage
At the NEI Fall Congress, Leading Faculty Reflect on the Evolution of Psychiatry and What the Future May Hold
11/08/2024
Brionna Mendoza
The 2024 Neuroscience Education Institute (NEI) Fall Congress commenced with opening remarks from Andrew J. Cutler, MD, Chairman, and the highly anticipated keynote address from Stephen M. Stahl, MD, PhD, DSc (Hon.), Chairman Emeritus.
The 2024 Neuroscience Education Institute (NEI) Fall Congress commenced with opening remarks from Andrew J. Cutler, MD, Chairman, and the highly anticipated keynote address from Stephen M. Stahl, MD, PhD, DSc (Hon.), Chairman Emeritus.
The 2024 Neuroscience Education...
11/08/2024
Psych Congress Network
NEI Fall Congress 2024
Conference Coverage
Medication Management, Care Enhancements Under the Spotlight at the 20th Annual NEI Fall Congress
11/07/2024
The 20th annual NEI Fall Congress provides a space—both in person and online—where leading minds in psychiatry share current and emerging treatment strategies with the next generation of mental health care professionals.
The 20th annual NEI Fall Congress provides a space—both in person and online—where leading minds in psychiatry share current and emerging treatment strategies with the next generation of mental health care professionals.
The 20th annual NEI Fall...
11/07/2024
Psych Congress Network

About Us

Neurology Learning Network is an online resource for the latest developments in clinical practice, providing a customized experience for readers to stay informed about the topics that matter most to them.

We are also the official media partner of NEI Congress and Alzheimer's Disease & Cognitive Disorders Symposium.

News

older adult resting hands on cane
Research Summary
Vascular Risk Factors Associated With Late-Onset Epilepsy in Older Adults
10/22/2026
Maria Mantas
Several vascular risk factors, including smoking, hypertension, diabetes and prior stroke, were associated with LOE in older adults, according to pooled analysis findings.
Several vascular risk factors, including smoking, hypertension, diabetes and prior stroke, were associated with LOE in older adults, according to pooled analysis findings.
Several vascular risk factors,...
10/22/2026
Neurology
trees with leaves falling to represent dementia progression
News
Global Dementia Cases Projected to Double by 2050
10/15/2026
Maria Mantas
A meta-analysis of 38,418 participants across 18 countries or territories estimated 11.4 million new dementia cases globally in 2023, with annual incidence projected to reach 24.7 million by 2050.
A meta-analysis of 38,418 participants across 18 countries or territories estimated 11.4 million new dementia cases globally in 2023, with annual incidence projected to reach 24.7 million by 2050.
A meta-analysis of 38,418...
10/15/2026
Neurology
a physician fills out a discharge form while speaking to a patient
Research Summary
Early Ocrelizumab Shows Sustained Long-Term Benefit in Relapsing MS
10/06/2026
Maria Mantas
Treatment with ocrelizumab for up to 10 years was associated with sustained relapse control and minimal disability accrual in patients with relapsing MS, according to phase 3 findings.
Treatment with ocrelizumab for up to 10 years was associated with sustained relapse control and minimal disability accrual in patients with relapsing MS, according to phase 3 findings.
Treatment with ocrelizumab for...
10/06/2026
Neurology
a hand points to a specific spot on a brain scan
News
P2Y12 Inhibitors Linked to Worse Intracerebral Hemorrhage Outcomes in Nationwide Study
07/13/2026
Maria Mantas
A nationwide cohort study found that prior use of P2Y12 inhibitors, either alone or combined with aspirin, was associated with more severe presentation and worse hospital outcomes in patients with spontaneous ICH.
A nationwide cohort study found that prior use of P2Y12 inhibitors, either alone or combined with aspirin, was associated with more severe presentation and worse hospital outcomes in patients with spontaneous ICH.
A nationwide cohort study found...
07/13/2026
Neurology
a researcher holds up a test tube of blood
News
Plasma p-tau217/Aβ42 Test Accuracy Reduced in Patients With Traumatic Brain Injury
07/06/2026
Maria Mantas
Plasma p-tau217/Aβ42 ratio accurately detected amyloid-PET positivity in veterans without traumatic brain injury (TBI), but accuracy declined significantly in those with prior TBI. 
Plasma p-tau217/Aβ42 ratio accurately detected amyloid-PET positivity in veterans without traumatic brain injury (TBI), but accuracy declined significantly in those with prior TBI. 
Plasma p-tau217/Aβ42 ratio...
07/06/2026
Neurology
doctor holds hands with an older woman patient sitting on the couch
News
Higher Parity May Accelerate Preclinical Alzheimer’s Changes in Postmenopausal Women
06/29/2026
Maria Mantas
A longitudinal study reports that parity may modify the relationship between Alzheimer disease (AD) pathology and brain aging in cognitively unimpaired postmenopausal women.
A longitudinal study reports that parity may modify the relationship between Alzheimer disease (AD) pathology and brain aging in cognitively unimpaired postmenopausal women.
A longitudinal study reports...
06/29/2026
Neurology
an older woman sits on a couch looking out the window
Research Summary
Frontal Release Signs Linked to Future Dementia Risk in Older Adults
06/17/2026
Maria Mantas
The presence of frontal release signs (FRS), primitive reflexes that reemerge with neurodegeneration or brain injury, may help identify older adults at increased risk for future cognitive decline, according to a cohort study.
The presence of frontal release signs (FRS), primitive reflexes that reemerge with neurodegeneration or brain injury, may help identify older adults at increased risk for future cognitive decline, according to a cohort study.
The presence of frontal release...
06/17/2026
Neurology
a doctor reviews brain scans
News
Reperfusion-Guided Blood Pressure Strategy May Improve Stroke Outcomes
06/09/2026
Maria Mantas
A multicenter randomized clinical trial found that reperfusion-guided systolic blood pressure (BP) management after successful endovascular therapy improved 90-day functional outcomes compared with guideline-recommended care.
A multicenter randomized clinical trial found that reperfusion-guided systolic blood pressure (BP) management after successful endovascular therapy improved 90-day functional outcomes compared with guideline-recommended care.
A multicenter randomized...
06/09/2026
Neurology
a strand of RNA
News
SKY-0515 Shows Sustained Biomarker Reductions in Huntington’s Disease
06/01/2026
Maria Mantas
SKY-0515, an investigational oral RNA splicing modifier, reduced mutant huntingtin (mHTT) protein levels in blood by up to 69% and PMS1 mRNA by up to 26% in a phase 1/2 Huntington’s disease (HD) trial. 
SKY-0515, an investigational oral RNA splicing modifier, reduced mutant huntingtin (mHTT) protein levels in blood by up to 69% and PMS1 mRNA by up to 26% in a phase 1/2 Huntington’s disease (HD) trial. 
SKY-0515, an investigational...
06/01/2026
Neurology
a man lays in bed unable to sleep
News
Accelerometer Sleep Metrics Linked to Dementia Risk in Older Adults
05/26/2026
Maria Mantas
Disruptions in sleep-wake cycles may provide scalable early markers for dementia risk in older adults, according to cohort study findings.
Disruptions in sleep-wake cycles may provide scalable early markers for dementia risk in older adults, according to cohort study findings.
Disruptions in sleep-wake cycles...
05/26/2026
Neurology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use